人工智能驱动与传统影像组学模型通过多参数成像预测膀胱癌肌层浸润:系统综述与Meta分析
该系统综述与Meta分析纳入43项研究共9624例患者,评估人工智能驱动与传统影像组学模型检测肌层浸润性膀胱癌的诊断效能,汇总AUC为0.92,敏感度与特异度均为0.86,但研究间存在显著异质性,结论认为需跨国多中心前瞻性队列研究验证外部效度。
要点
- 影像组学模型检测肌层浸润性膀胱癌汇总AUC 0.92、敏感度0.86、特异度0.86。
- 汇总阳性似然比5.97、阴性似然比0.17、诊断比值比35.57。
- 研究间异质性显著,来源包括中心类型、样本量、数据集分类、成像方式、算法、验证方法、分割方法、地区差异和偏倚风险。
核心结论
- 人工智能驱动与传统影像组学模型对肌层浸润性膀胱癌表现出稳健的诊断性能,但研究间大量异质性需通过跨国多中心前瞻性队列研究验证以建立外部效度。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南,检索PubMed、Web of Science、Embase和Cochrane Library数据库至2025年5月13日并手动筛选纳入研究参考文献,纳入43项研究共9624例患者,使用QUADAS-2和影像组学质量评分(RQS)评估质量与偏倚风险,平均RQS为18.89。
诊断标准与关键数值
- 汇总AUC为0.92(95%CI 0.89-0.94),汇总敏感度和特异度均为0.86(95%CI 0.84-0.87),敏感度异质性I²=43.58、特异度异质性I²=72.76。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 所有纳入研究均存在显著异质性(P<0.1)。
- 汇总诊断比值比异质性I²=99.92。
- 研究间异质性来源包括研究中心类型(单中心与多中心)、样本量(<100与≥100例患者)、数据集分类(训练、验证、测试或未分组)、成像方式(CT与MRI)、建模算法(深度学习、机器学习或其他)、验证方法(交叉验证与队列验证)、分割方法(手动与(半)自动)、地区差异(中国与其他国家)以及偏倚风险(高、低或不明确)。
- 需通过跨国多中心前瞻性队列研究验证以建立外部效度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study systematically evaluates the diagnostic performance of artificial intelligence (AI)-driven and conventional radiomics models in detecting muscle-invasive bladder cancer (MIBC) through meta-analytical approaches. Furthermore, it investigates their potential synergistic value with the Vesical Imaging-Reporting and Data System (VI-RADS) and assesses clinical translation prospects.
METHODS: This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We conducted a comprehensive systematic search of PubMed, Web of Science, Embase, and Cochrane Library databases up to May 13, 2025, and manually screened the references of included studies. The quality and risk of bias of the selected studies were assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) and Radiomics Quality Score (RQS) tools. We pooled the area under the curve (AUC), sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and their 95% confidence intervals (95% CI). Additionally, meta-regression and subgroup analyses were performed to identify potential sources of heterogeneity.
RESULTS: This meta-analysis incorporated 43 studies comprising 9624 patients. The majority of included studies demonstrated low risk of bias, with a mean RQS of 18.89. Pooled analysis yielded an AUC of 0.92 (95% CI: 0.89-0.94). The aggregate sensitivity and specificity were both 0.86 (95% CI: 0.84-0.87), with heterogeneity indices of I² = 43.58 and I² = 72.76, respectively. The PLR was 5.97 (95% CI: 5.28-6.75, I² = 64.04), while the NLR was 0.17 (95% CI: 0.15-0.19, I² = 37.68). The DOR reached 35.57 (95% CI: 29.76-42.51, I² = 99.92). Notably, all included studies exhibited significant heterogeneity (P < 0.1). Meta-regression and subgroup analyses identified several significant sources of heterogeneity, including: study center type (single-center vs. multi-center), sample size (<100 vs. ≥100 patients), dataset classification (training, validation, testing, or ungrouped), imaging modality (computed tomography [CT] vs. magnetic resonance imaging [MRI]), modeling algorithm (deep learning vs. machine learning vs. other), validation methodology (cross-validation vs. cohort validation), segmentation method (manual vs. [semi]automated), regional differences (China vs. other countries), and risk of bias (high vs. low vs. unclear).
CONCLUSION: AI-driven and traditional radiomic models have exhibited robust diagnostic performance for MIBC. Nevertheless, substantial heterogeneity across studies necessitates validation through multinational, multicenter prospective cohort studies to establish external validity.
引用
- Wang Z, Shi H, Wang Q, et al. AI-driven and Traditional Radiomic Model for Predicting Muscle Invasion in Bladder Cancer via Multi-parametric Imaging: A Systematic Review and Meta-analysis. Acad Radiol. 2025. PMID: 40914722. doi:10.1016/j.acra.2025.08.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。